The need to generate high quality clinical data to support medical device labeling claims has increased significantly over the last five years. This, coupled with an increasing requirement to provide substantial clinical data in the post-market setting in both US and Europe, has forced Medical Device and Diagnostic Companies to re-evaluate their approach to clinical development.